| Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study A Yoshimura, T Yamada, Y Okuma, A Fukuda, S Watanabe, N Nishioka, ... Translational Lung Cancer Research 10 (8), 3582, 2021 | 16 | 2021 |
| Unusual manifestation of disseminated herpes simplex virus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocytic lymphohisitocytosis without … S Kurosawa, N Sekiya, K Fukushima, K Ikeuchi, A Fukuda, H Takahashi, ... BMC Infectious Diseases 19, 1-6, 2019 | 12 | 2019 |
| High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib A Yoshimura, T Yamada, M Serizawa, H Uehara, K Tanimura, Y Okuma, ... Cancer science 114 (2), 606-618, 2023 | 11 | 2023 |
| Number of patients with influenza and COVID-19 coinfection in a single Japanese hospital during the first wave S Kawai, K Fukushima, M Yomota, A Fukuda, S Fujiwara, M Tanaka, ... Japanese Journal of Infectious Diseases 74 (6), 570-572, 2021 | 11 | 2021 |
| An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories A Fukuda, N Yanagawa, N Sekiya, K Ohyama, M Yomota, T Inui, ... Japanese Journal of Radiology 39, 783-790, 2021 | 8 | 2021 |
| Cisplatin and irinotecan as first-line chemotherapy for previously untreated metastatic thymic carcinoma: updated analysis A Fukuda, Y Okuma, T Hakozaki, K Mirokuji, M Yomota, T Hishima, ... Frontiers in Oncology 11, 779700, 2022 | 4 | 2022 |
| Treatment of advanced ALK-rearranged NSCLC following second-generation ALK–TKI failure A Fukuda, T Yoshida Expert Review of Anticancer Therapy 23 (11), 1157-1167, 2023 | 2 | 2023 |
| High levels of AXL expression in untreated EGFR-mutated NSCLC negatively impacts the use of osimertinib. A Yoshimura, T Yamada, M Serizawa, H Uehara, K Tanimura, Y Okuma, ... Cancer Science, 2022 | 1 | 2022 |
| How many coinfected patients with influenza and COVID-19 are there in a single Japanese hospital during the first wave? S Kawai, K Fukushima, M Yomota, A Fukuda, S Fujiwara, M Tanaka, ... Japanese Journal of Infectious Diseases, JJID. 2020.1009, 2021 | 1 | 2021 |
| Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis K Tamura, Y Okuma, S Nomura, A Fukuda, K Masuda, Y Matsumoto, ... Journal of Cancer Research and Clinical Oncology 150 (4), 216, 2024 | | 2024 |
| Differential therapeutic benefit of platinum-doublet chemotherapies with ICIs based on smoking status plus PD-L1 expression in advanced NSCLC patients. A Fukuda, T Yoshida, K Masuda, Y Shinno, Y Okuma, Y Goto, ... JCO Global Oncology 9 (Supplement_1), 148-148, 2023 | | 2023 |
| Differential therapeutic benefit of platinum-doublet chemotherapies with ICIs based on the classification by combined with smoking status and PD-L1 expression in patients with … A Fukuda, T Yoshida, K Masuda, Y Shinno, Y Okuma, Y Goto, ... Journal of Clinical Oncology 41 (16_suppl), e21131-e21131, 2023 | | 2023 |
| Real-world Data on the Incidence of Coronavirus Disease (COVID-19) in Patients With Advanced Thoracic Cancer During the Early Phase of the Pandemic in Japan A Fukuda, T Yoshida, S Yagishita, M Shiotsuka, O Kobayashi, S Iwata, ... Anticancer Research 43 (2), 919-926, 2023 | | 2023 |
| 1147P Effects of the use of antibiotics or antacids on chemoimmunotherapy prognostic factors in patients with advanced non-small cell lung cancer: A propensity-score-matched … K Tamura, Y Okuma, A Fukuda, K Masuda, Y Shinno, T Yoshida, Y Goto, ... Annals of Oncology 33, S1074, 2022 | | 2022 |
| Correction to: An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories A Fukuda, N Yanagawa, N Sekiya, K Ohyama, M Yomota, T Inui, ... Japanese Journal of Radiology 39 (10), 1022, 2021 | | 2021 |
| Retrospective analysis of outcomes of cisplatin and irinotecan combination chemotherapy for unresectable thymic carcinoma A Fukuda, M Yomota, Y Hosomi Annals of Oncology 30, ix176-ix177, 2019 | | 2019 |
| CASE REPORT Open Access S Kurosawa, N Sekiya, K Fukushima, K Ikeuchi, A Fukuda, H Takahashi, ... | | 2019 |
